Beckman Coulter, Inc. Securities Litigation

Berger Montague represented a class of shareholders and obtained a $5.5 million settlement in this securities fraud class action against the lab equipment maker, Beckman Coulter, Inc. The case was litigated in the United States District Court for the Central District of California.

The plaintiffs alleged that Beckman Coulter did not disclose product quality and regulatory issues that hurt the company’s stock price in a timely fashion. Specifically, the plaintiffs alleged that Beckman Coulter failed to disclose that modifications to its troponin test kits violated FDA regulations. When the company finally revealed this information, the stock price dropped.

If you are an investor and have questions about a potential securities fraud lawsuit, please contact Berger Montague.

About Berger Montague

Berger Montague is a national law firm focusing on complex civil litigation in federal and state courts throughout the United States. For over half a century, Berger Montague has played lead roles in consequential, precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago, Minneapolis, San Diego, San Francisco, Toronto, and Washington, D.C.